Exact Sciences CORP Schedule 13G passive stakes

The Vanguard Group filed an amendment to its Schedule 13G for Exact Sciences Corp, reporting 0% beneficial ownership due to an internal reporting realignment.

Exact Sciences Corporation and its subsidiary, Genomic Health, Inc., have reported a 12.0% beneficial ownership stake in MDxHealth SA ordinary shares.

FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reporting a 2.9% beneficial ownership stake in Exact Sciences Corp as of November 28, 2025.

Capital World Investors has filed an amended Schedule 13G, reporting an 8.5% beneficial ownership in Exact Sciences Corp. common stock.

Wellington Management Group LLP and its affiliates have reported a 3.04% beneficial ownership stake in Exact Sciences Corporation, holding 5,747,093 shares of common stock.

FMR LLC and its affiliates, including Abigail P. Johnson, reported a beneficial ownership of 9.8% in Exact Sciences Corp, totaling over 18.5 million shares.

BlackRock, Inc. has filed an Amendment No. 3 to its Schedule 13G, disclosing a 4.3% beneficial ownership stake in Exact Sciences Corp. as of June 30, 2025.

Capital World Investors has filed an amended Schedule 13G, revealing a beneficial ownership of 9.6% of Exact Sciences Corp.'s common stock as of March 31, 2025.

FMR LLC and its Chairman and CEO, Abigail P. Johnson, have filed an amended Schedule 13G, disclosing a combined beneficial ownership of 15.0% of Exact Sciences Corp's common stock as of March 31, 2025.

Wellington Management Group LLP and its affiliates have disclosed a passive beneficial ownership of 6.7% in Exact Sciences Corporation, totaling 12,394,303 common shares as of December 31, 2024.